Bayer today announced that its MEDRAD® Centargo multi-patient CT injector has secured 510(k) clearance from the U.S. Food and Drug Administration (FDA) to expand the use of compatible contrast agent ...
Bayer announced today 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its MEDRAD ® Centargo CT Injection System, an innovative multi-patient injector that drives workflow ...
Centargo compatible with Ultravist® (iopromide), Isovue® (iopamidol), Optiray® (ioversol), Omnipaque™ (iohexol) and now, Visipaque™ (iodixanol) Follows recent FDA clearance to expand the use of ...
Follows recent FDA clearance to expand the use of compatible contrast agent presentations, adding single-dose vials in addition to Imaging Bulk Package presentations Radiology suites now have the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback